How the FDA was allowed to approve drugs for sale on e-cigarettes that could kill people

How the FDA was allowed to approve drugs for sale on e-cigarettes that could kill people

August 2, 2021 Comments Off on How the FDA was allowed to approve drugs for sale on e-cigarettes that could kill people By admin

By Mike DeBonisAssociated PressPublished Mar 10, 2018 2:00AM ETRead moreThe U.S. Food and Drug Administration approved a batch of e-cigarette products containing nicotine on Wednesday, allowing them to be sold in the U.K. and Canada, the U and European Union’s regulators said.

The approval came just hours after British Prime Minister Theresa May called for the FDA to reverse its decision to approve the products in the wake of a string of fatal e-cig-related deaths in the country.

The U, EU and Canada are the first countries to allow the sale of e‐cigarettes with nicotine in them, which have come under fire from public health officials who say they may increase smoking.

The FDA’s decision came after the FDA’s inspector general found problems with the e-cigs.

In an analysis of a batch, the FDA found a number of issues that led to the agency’s approval of a product that contains nicotine, which is a naturally occurring chemical in the tobacco plant.

Those issues included a small amount of tobacco in the package that is not the same amount as the amount found in tobacco products sold in tobacco shops, and the FDA also found nicotine in some of the e‐cigs’ batteries that were too small to fit into a cartridge.

In a statement, the European Commission said it will review the FDA decision.

The UK and Canadian governments said they will review it.